课题基金 / 基金详情

PFI-RP: Brain-controlled Upper-Limb Robot-Assisted Rehabilitation Device for Stroke Survivors.

PFI-RP: Brain-controlled Upper-Limb Robot-Assisted Rehabilitation Device for Stroke Survivors.
PFI-RP:用于中风幸存者的脑控上肢机器人辅助康复装置。
批准号:
1827769
负责人:
Jose Contreras-Vidal
金额:
$75.0万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-15 至 2024-08-31

项目摘要

项目成果

Jose Contreras-Vidal的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The broader impact/commercial potential of this PFI project is to advance the national health by accelerating the development, efficacy and use of brain-controlled robotic rehabilitation after stroke by capitalizing on the benefits of non-invasive brain interfaces that extract information about the patient?s motor intent and the real-time assessment of impairment and recovery of motor function. Stroke is the leading cause of neurological disability in the United States with approximately 795,000 people suffering a stroke each year. Arm paresis is a primary cause of disability because of the limitations it creates in performing activities of daily living (ADL). Approximately 80% of all stroke survivors suffer from upper limb paresis and only 18% of these individuals gain full motor recovery with conventional treatments in the year following stroke. Thus, rehabilitation of the impaired limb is essential for improving ADLs and quality of life after stroke, yet only 31% of stroke survivors receive outpatient rehabilitation. Brain-controlled robotic devices are excellent candidates for engaging the patients and delivering the repetitive and intensive practice stroke survivors require for rehabilitation. Our innovative robotic rehabilitation solution will offer increased efficiency, lower expenses, and new sensing capabilities to the therapist while reducing the socioeconomic burden of disability. The proposed project addresses a pressing need for accessible, safe and effective stroke rehabilitation devices for in-clinic and at-home use for sustainable long-term therapy, a global market size expected to reach $31B by 2021. Unfortunately, current devices fail to engage the patients, are hard to match to their needs, are costly to use and maintain, or are limited to clinical settings. Our patient-in-the-loop system solution consists of our patented noninvasive brain-robot technology that translates the user's brain activity into motor commands to drive powered, assist-as-needed, upper-limb robotics for stroke rehabilitation. Feedback of performance will be provided to both the patient and the clinician, and stored for monitoring and diagnostics, through a user interface that also serves to provide engaging real-time feedback of task and associated completion performance. System validation will occur in a clinical setting and at home. The Intellectual Merits include addressing the challenges of fault-tolerant system integration, low-cost device prototyping, usability, shared-control, acquiring validation data, and accelerating the translation to the patient for a new class of biomedical devices. The deliverable is an accessible, safe and effective brain-controlled therapeutical robot system that is multi-functional with real-time self-monitoring, self-diagnostics and self-correcting capabilities, and that promotes neurorecovery of function.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1088/1741-2552/ab2b61
发表时间: 2019-10-01
期刊: JOURNAL OF NEURAL ENGINEERING
影响因子: 4
作者: [Kilicarslan, Atilla, Vidal, Jose Luis Contreras]
通讯作者: Vidal, Jose Luis Contreras
A Novel Headset System Synchronizing Vision and EEG testing for a Rapid Assessment and Diagnosis of Concussions and Other Brain Injuries
一种同步视觉和脑电图测试的新型耳机系统,用于快速评估和诊断脑震荡和其他脑损伤
DOI: 10.54941/ahfe1002125
发表时间: 2022
期刊: AHFE International
影响因子: --
作者: [Edquilang, David, Feng, Jeff]
通讯作者: Feng, Jeff
DOI: --
发表时间: 2023
期刊: and Cybernetics (SMC
影响因子: --
作者: [Gonzalez-Espana, Jose J., Craik, Alexander, Ramirez, Carolina, Alamir, Ayman, and Contreras-Vidal, Jose]
通讯作者: and Contreras-Vidal, Jose
DOI: 10.1109/smc53992.2023.10394117
发表时间: 2023-10
期刊: 2023 IEEE International Conference on Systems, Man, and Cybernetics (SMC)
影响因子: --
作者: [Juan José González-España;Lianne Sánchez Rodríguez;Alexander Craik;Sarah Wong;Jeff Feng;J. Contreras-Vidal]
通讯作者: Juan José González-España;Lianne Sánchez Rodríguez;Alexander Craik;Sarah Wong;Jeff Feng;J. Contreras-Vidal
7
    IUCRC Phase II: Building Reliable Advances and Innovations in Neurotechnology (BRAIN)
    • 批准号:
      2137255
    • 项目类别:
      Continuing Grant
    • 资助金额:
      $75.83万
    • 财政年份:
      2022
    • 负责人:
      Jose Contreras-Vidal
    • 依托单位:
    REU Site: Neurotechnologies to Help the Body Move, Heal, and Feel Again
    • 批准号:
      2150415
    • 项目类别:
      Standard Grant
    • 资助金额:
      $40.25万
    • 财政年份:
      2022
    • 负责人:
      Jose Contreras-Vidal
    • 依托单位:
    WORKSHOP: Doctoral Consortium at the 2019 International Graphonomics Conference: Graphonomics and Your Brain on Art, Creativity and Innovation
    • 批准号:
      1933178
    • 项目类别:
      Standard Grant
    • 资助金额:
      $1.5万
    • 财政年份:
      2019
    • 负责人:
      Jose Contreras-Vidal
    • 依托单位:
    REU Site: Neurotechnologies to Help the Body Move, Heal, and Feel Again
    • 批准号:
      1757949
    • 项目类别:
      Standard Grant
    • 资助金额:
      $42.74万
    • 财政年份:
      2018
    • 负责人:
      Jose Contreras-Vidal
    • 依托单位:
    国内基金
    海外基金
    新型lncRNA RP11-386G11.10通过ceRNA网络调控miR-345-3p/CREB5轴促进黑色素瘤进展的机制探索
    • 批准号:
      2026JJ81952
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      党委
    • 依托单位:
    LncRNA RP11介导肿瘤细胞与肺驻留型巨 噬细胞互作抑制乳腺癌肺转移的机制研 究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      罗利云
    • 依托单位:
    基于患者来源类器官模型探究基因编辑技术对PRPF6突变RP疾病的作用
    银杏双黄酮通过靶向鞘脂代谢异常的SPHK1+基质相关CAFs亚群以抑制S1P-S1RP3信号轴从而增敏第三代EGFR-TKIs的机制研究
    • 批准号:
      QN25H290015
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      戴淑颖
    • 依托单位: